Case Report

Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation

Table 1

An overview of relevant laboratory parameters during the clinical course of the patient.

ParametersReference rangeAdmission Day 0Day 5Day 1 of HLH-04 protocolDay 5 of HLH-04 protocolDay 10 of HLH-04 protocolDay 15 of HLH-04 protocolDay 20 of HLH-04 protocolDay of discharge

Hemoglobin (g/-dL)13.0–18.08.77.810.810.29.78.28.59.5
Neutrophils (109xL)2.0–7.50.80.990.750.921.020.790.423.44
Lymphocytes (109/L)1.5–4.01.611.071.442.30.480.410.842.16
Platelet count (109/L)150–450635441876869221273
Ferritin (μg/L)11–1721420191294818211612976881371
Fibrinogen (g/L)2.0–4.01.51.60.91.21.41.61.9
Triglyceride (mmol/L)0.5–2.203.13
Direct bilirubin (μmol/L)1.7–6.7208034
ALT (IU/L)9–24502707611323303257274128
AST (IU/L)14–35354608390189113798963
ALP (IU/L)59–164994885967631413305309253
GGT (IU/L)7–212502195694245356477821025
sIL-2r (U/ml)158–62315900